NOV-202

N/A

Report date: 2025/04/21 11:21:45
NME

Base Information

Drug NameNOV-202
Drug Alias NameNOV-202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitorsVascular disrupting agents (VDA)
TargetsTubulin
Therapy Area/IndicationsBrain NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNoviga Research AB
China Registration ClassN/A

Develop Information

Active CompaniesNoviga Research AB
Inactive CompaniesN/A
Active IndicationsBrain Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A